A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(29 sites)

United States

City of Hope, Duarte, California

University of California San Francisco, San Francisco, California

UHealth Diabetes Research Institute, Miami, Florida

Northwestern Organ Transplant Center, Chicago, Illinois

University of Chicago, Chicago, Illinois